Chemical genomics strategy for the discovery of new anticancer agents

Current Medicinal Chemistry

Volumn 10, Issue 9, 2003, Pages 757-762

  Jung, Mankil ^a   Kim, Hanjo ^a   Kim, Myosun ^a  

^a Yonsei University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; AROMATASE INHIBITOR; CAMPTOTHECIN; CHOLINE KINASE; CYTOCHROME P450 17; CYTOCHROME P450 INHIBITOR; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE INHIBITOR; ETOPOSIDE; FIBROBLAST GROWTH FACTOR RECEPTOR 1; GLUTAMIC ACID DERIVATIVE; GLUTAMINE DERIVATIVE; INDOLE ALKALOID; IRINOTECAN; ISOQUINOLINE DERIVATIVE; LIGAND; NEW DRUG; PODOPHYLLOTOXIN; PROTEIN KINASE C DELTA; PROTEIN KINASE C INHIBITOR; PROTEIN TYROSINE KINASE; RIBONUCLEOTIDE REDUCTASE; TENIPOSIDE; TOPOTECAN;

ANTINEOPLASTIC ACTIVITY; BIODIVERSITY; BREAST CANCER; COLON CARCINOMA; DRUG BINDING; DRUG DESIGN; DRUG SCREENING; DRUG STRUCTURE; DRUG TARGETING; GENOMICS; HUMAN; METHODOLOGY; MOLECULAR LIBRARY; OVARY CARCINOMA; PROSTATE CARCINOMA; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW; VALIDATION PROCESS;

ANIMALS; ANTINEOPLASTIC AGENTS; DRUG DESIGN; GENOMICS; HUMANS; LIGANDS; MODELS, MOLECULAR; NEOPLASMS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0037262086     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/0929867033457782     Document Type: Review

References (56)

1. Chen, A. Y.; Liu, L. F. Annu. Rev. Pharmacol. Toxicol. 1994, 94, 194-218.
2. Wall, M. E.; Wani, M. C.; Cooke, C. E.; Palmer, K. H.; McPhail, A. T.; Slim, G. A. J. Am. Chem. Soc. 1966, 88, 3888-3890.
3. Ozols, R. F. Int. J. Gynecol. Cancer 2000, 10, 33-37.
4. Saltz, L. B.; Cox, J. V.; Blanke, C.; Rosen, L. S.; Fehrenbacher, L.; Moore, M. J.; Maroun, J. A.; Ackland, S.P.; Locker, P. K.; Pirotta, N.; Elfring, G. L.; Miller, L. L. N. Engl. J. Med. 2000, 343, 905-914.
5. Laco, G. S.; Collins, J. R.; Luke, B. T.; Kroch, H.; Sayer, J. M.; Jerina, D. M.; Pommier, Y. Biochemistry 2002, 41, 1428-1435.
6. Brodie, A. M. H.; Njar, V. C. O. Steroids 2000, 65, 171-179.
7. Banting, L. Prog. Med Chem. 1996, 33, 147-184.
8. Van Wauwe, J. P.; Janssen, P. A. J. Med. Chem. 1989, 32, 2231-2239.
9. Hartmann, R. W. Eur. J. Pharm. Sci. 1994, 2, 15-16.
10. Cavalli, A.; Recanatini, M. J. Med. Chem. 2002, 45, 251-254.
11. Furet, P.; Batzl, C.; Francotte, E.; Rihs, G.; Lang, M. J. Med. Chem. 1993, 36, 1393-1400.
12. Koynans, L. M. H.; Moereels, H.; Vanden Bossche, H. J. Steroid Biochem. Mol. Biol. 1995, 53, 191-197.
13. Brohm, D.; Metzget, S.; Bhargava, A.; Müller, O.; Lieb, F.; Waldmann, H. Angew. Chem. Int. Ed. 2002, 41, 311-317.
14. Stahl, P.; Kissau, L.; Mazitschek, R.; Huwe, H.; Furet, P.; Giannis, A.; Waldmann, H. J. Am. Chem. Soc. 2001, 123, 11586-11593.
15. Stahl, P.; Kissau, L.; Mazitschek, R.; Giannis, A.; Waldmann, H. Angew. Chem. Int. Ed. 2002, 41, 1174-1178.
16. Shewchuk, L. M.; Hassell, A. M.; Ellis, B.; Holmes, W. D.; Davies, R.; Horne, E. L.; Kadwell, S. H.; McKee, D. D.; Moore, J. T. Structure 2000, 6, 1105-113.
17. Mohammadi, M.; Schlessinger, J.; Hubbard, S. R. Cell 1996, 86, 577-587.
18. Monks, A.; Scudiero, D. A.; Shoemaker, R. H.; Paull, K. D.; Vistica, D.; Hose, C.; Langley, J.; Cronise, P.; Vaigro-Wolff, A.; Gray-Goodrich, M.; Campell, H.; Mayo, J.; Boyd, M. R. J. Natl. Cancer Inst. 1991, 83, 757-766.
19. Boyd, M. R.; Paull, K. D. Drug Dev. Res. 1995, 34, 91-109.
20. Morris, G. M.; Goodsell, D. S.l Halliday, R. S.; Huey, R.; Hart, W. E.; Below, R. K.; Olson, A. J. J. Comput. Chem. 1998, 19, 1639-1662.
21. Shao, L.; Lewin, N. E.; Lorenzo, P. S.; Hu, Z.; Enyedy, I. J.; Garfield, S. H.; Stone, J. C,.; Marner, F. J.; Blumberg, P. M.; Wang, S. J. Med. Chem. 2001, 44, 3872-3880.
22. Issell, B. F. Cancer Chemother. Pharmacol. 1982, 7, 73-80.
23. Xiao, Z.; Xiao, Y-. D.; Feng, J.; Golbraikh, A.; Tropsha, A.; Lee K-. H. J. Med. Chem. 2002, 45, 2294-2309.
24. Zheng, W.; Tropsha, A. J. Chem. Inf. Comput. Sci. 2000, 40, 185-194.
25. Kier, L. B.; Hall, L. H. Molecular Structure Description-The Electrotopological State; Academic Press: San Diego, 1999.
26. http://www.chemcomp.com
27. Medina, M. J. Nutr. 2001, 131(9), 2539S-2542S.
28. Costa, C.; Huneau, J. F.; Tome, D. Biochem. Biophys. Acta/Biomembranes 2000, 1509, 95-102.
29. Collins, C. L.; Wasa, M.; Souba, W. W.; Abcouwer, S. F. J. Cell. Physiol. 1998, 176, 166-178.
30. Sukemori, S.; Sugimura, K. Cancer Biochem. Biophys. 1994, 14, 99-105.
31. Devreker, F.; Winston, R. M.; Hardy, K. Fertil. Steril. 1998, 69, 293-299.
32. Kang, Y. J.; Feng, Y.; Hatcher, E. L. J. Cell. Physiol. 1994, 161, 589-596.
33. Kang, Y. J. Cell. Mol. Biol. Res. 1993, 39, 675-684.
34. Ollenschlager, G.; Simmel, A.; Roth, E. Metabolism 1989, 38, S40-S42.
35. Srikanth, K.; Debnath, B.; Jha, T. Bioorg. Med. Chem. 2002, 10, 1841-1854.
36. Srikanth, K.; Kumar, C. A.; Ghosh, B.; Jha, T. Bioorg. Med. Chem. 2002, 10, 2119-2131.
37. Garg, R.; Gupta, S. P.; Gao, H.; Badu, M. S.; Debnath, A. K.; Hansch, C. Chem. Rev. 1999, 99, 3525-3601.
38. Cuardrado, A.; Carnero, A.; Dolfi, F.; Jiménez, B.; Lacal, J. C. Oncogene 1993, 8, 2959-2968.
39. Jiménez, B.; del Peso, L.; Montaner, S.; Esteve, P.; Lacal, J. C. J. Cell. Biochem. 1995, 57, 141-149.
40. Hernández-Alcoceba, R.; Saniger, L.; Campos, J.; Núñez, M. C.; Khaless, F.; Gallo, M. A.; Espinosa, A.; Lacal, J. C. Oncogene 1997, 15, 2289-2301.
41. Hernández-Alcoceba, R.; Fernández, F.; Lacal, J. C. Cancer Res. 1999, 59, 3112-3118.
42. Campos, J. M.; Núñez, M. C.; Sánchez, R. M.; Gómez-Vidal, J. A.; Rodríguez-González, A.; Báñez, M.; Gallo, M. A.; Lacal, J. C.; Espinosa, A. Bioorg. Med. Chem. 2002, 10, 2215-2231.
43. Viswandadhan, V. M.; Ghose, A. K.; Revankar, G. R.; Robins, R. K. J. Chem. Inf. Comput. Sci. 1989, 29, 163-172.
44. CompuDrug Chemistry, Ltd. PO Box 23196, Rochester, NY 14692, USA.
45. Nocentini, G. Crit. Rev. Oncol. Hematol. 1996, 22, 89-126.
46. Das, A.; Trousdale, M. D.; Ren, S. J.; Lien, E. J. Antiviral Res. 1999, 44, 201-208.
47. Finch, R. A.; Liu, M.; Grill, S. P.; Rose, W. C.; Loomis, R.; Basquez, K. M.; Cheng, Y.; Sartorelli, A. C. Biochem. Pharmacol. 2000, 59, 983-991.
48. Szekeres, T.; Fritzer-Szekeres, M.; Elford, H. L. Crit. Rev. Clin. Lab. Sci. 1997, 34, 503-528.
49. Ren, S.; Wang, R. Komatsu, K.; Bonaz-Krause, P.; Zyrianov, Y.; McKenna, C. E.; Csipke, C. Tokes, Z. A.; Lien, E. J. J. Med. Chem. 2002, 45, 410-419.
50. CQSAR program and database, BioByte Corp. (201 W, 4th Street, Suite 204, Claremont, CA 91711), 2001.
51. Buttke, T. M.; McCubrey, J. A.; Owen, T. C. J. Immunol. Methods 1993, 157, 233-240.
52. Baltrop, J. A.; Owen, T. C.; Cory, A. H.; Cory, J. G. Bioorg. Med. Chem. Lett. 1991, 1, 611-614.
53. Cho, W. J.; Kim, E. K.; Park, I. Y.; Jeong, E. Y.; Kim, T. S., Le, T. N.; Kim, D. D.; Lee, E. S. Bioorg. Med. Chem. 2002, 10, 2953-2961.
54. Cho, W. J.; Kim, E. K.; Park, M. J.; Choi, S. U.; Lee, C. O.; Cheon, S. H.; Choi, B. G. Chung, B. H. Bioorg. Med. Chem. 1998, 6, 2449-2458.
55. Merino, A.; Madden, K. R.; Lane, W. S.; Champoux, J. J.; Deinberg, D. Nature 1993, 365, 227-232.
56. Jiang, B.; Xiong, W. N.; Yang, C. G.; Jiang, H. L.; Cheng, F.; Chen, K. X. Bioorg. Med. Chem. 2002, 10, 2775-2778.